Tamoxifen for Breast Cancer: 5 Years vs. 10 Years – Which is More Effective?
In this video, Dr. Jennifer Griggs explains why Tamoxifen is prescribed for 5-10 years, especially for those with estrogen receptor-positive (ER+) breast cancer. She compares the outcomes of taking Tamoxifen for 5 years versus 10 years, highlighting the benefits and risks of extended use. #tamoxifen #breastcancertreatment #breastcancer
Get your personalized Yerbba Report at https://www.yerbba.com/
Connect With Yerbba!
INSTAGRAM: / yerbba
FACEBOOK: / yerbba.breast.cancer
BLOG: https://www.yerbba.com/blog
Sources
1. Early Breast Cancer Trialists' Collaborative Group. Tamoxifen for early breast cancer: an overview of the randomised trials. https://pubmed.ncbi.nlm.nih.gov/9605801/
2. NCI. 10 Years of Tamoxifen. https://www.cancer.gov/types/breast/r...
Chapters
0:00 Introduction
0:36 - Introduction to Tamoxifen
1:08 - Why is Tamoxifen Prescribed for 5-10 Years?
3:21 - 5 Years vs. 10 Years: Which Offers Better Protection?
5:39 - Does Tamoxifen Beyond 10 Years Add Benefits?
5:52 - Long-Term Risks of Tamoxifen
Disclaimer: Yerbba YouTube videos are for informational purposes only, do not constitute medical advice, and are not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your medical team, mental health professional, or other qualified health provider with any questions you may have regarding your medical condition.
